Silicon Valley’s psychedelic wonder drug is almost here | Curio

Silicon Valley’s psychedelic wonder drug is almost here

17 mins | Dec 16, 2019

A new startup is hoping to cure depression, opioid addiction and alcoholism. Ruth Reader investigates how MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment while cutting out the downsides of tripping. But, with only anecdotal evidence of its effectiveness, will it even work?

publisher logo

From Fast Company

Read along